Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dyne Therapeutics, Inc.COM(DYN) | 7,845,364 | 5,954,069 | -1,891,295 | $276.86M | $213.87M | 36.73% | -$62.99M |
| NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES ORDINARY SHARES | 11,831,461 | 11,831,461 | 0 | $227.28M | $196.40M | 33.73% | -$30.88M |
| ENGENE HOLDINGS INCCOM COM | 8,677,951 | 8,677,951 | 0 | $81.83M | $57.27M | 9.84% | -$24.56M |
| Replimune Group, Inc.COM(REPL) | 4,866,449 | 4,866,449 | 0 | $43.80M | $53.34M | 9.16% | +$9.54M |
| BICYCLE THERAPEUTICS PLCSPONSORED ADS | 2,122,892 | 2,339,961 | +217,069 | $42.97M | $52.95M | 9.09% | +$9.99M |
| ENGENE HOLDINGS INCW EXP 10/31/2028 *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | $3.42M | $6.04M | 1.04% | +$2.62M |
| ACHILLES THERAPEUTICS PLCSPONSORED ADS | 2,390,050 | 2,390,050 | 0 | $1.95M | $2.44M | 0.42% | +$490.0K |